Low Oxygen Triggers Blood-Brain Barrier Cells to Produce More Adrenomedullin
Hypoxia upregulated both adrenomedullin production and its receptor in brain astrocytes and endothelial cells, suggesting a coordinated protective response at the blood-brain barrier during ischemia.
Quick Facts
What This Study Found
Hypoxia induced coordinated upregulation of adrenomedullin and its receptor RDC-1 in brain astrocytes and endothelial cells, with NF-κB-mediated transcriptional activation, suggesting an autocrine/paracrine protective mechanism at the blood-brain barrier.
Key Numbers
How They Did This
In-vitro study using cultured rat brain astrocytes and endothelial cells. Hypoxia exposure with measurement of ADM mRNA, protein, and RDC-1 receptor expression. Gene reporter assays identified NF-κB involvement.
Why This Research Matters
Stroke and brain ischemia cause devastating damage. Understanding the brain's built-in protective responses, including ADM upregulation, could lead to therapies that enhance these natural defenses during stroke.
The Bigger Picture
The brain has evolved sophisticated self-protective mechanisms for oxygen deprivation. ADM's coordinated upregulation with its receptor ensures the protective signal is both produced and received at the blood-brain barrier.
What This Study Doesn't Tell Us
In-vitro study in isolated cells. The in-vivo relevance of this coordinated upregulation during actual stroke or ischemia needs confirmation.
Questions This Raises
- ?Could ADM administration protect the brain during stroke?
- ?Does the coordinated receptor upregulation explain why ADM is effective at the blood-brain barrier?
- ?Can the NF-κB pathway be targeted to enhance ADM-mediated brain protection?
Trust & Context
- Key Stat:
- Coordinated upregulation Both the vasodilatory peptide ADM and its receptor increased together during hypoxia — ensuring the protective signal is both made and received
- Evidence Grade:
- Preliminary in-vitro evidence with clear mechanistic data including transcription factor identification, but lacking in-vivo confirmation.
- Study Age:
- Published in 2000. Adrenomedullin's neuroprotective role during ischemia has been further characterized, supporting its potential in stroke therapy.
- Original Title:
- Coordinated Up-regulation by hypoxia of adrenomedullin and one of its putative receptors (RDC-1) in cells of the rat blood-brain barrier.
- Published In:
- The Journal of biological chemistry, 275(51), 39914-9 (2000)
- Database ID:
- RPEP-00600
Evidence Hierarchy
Frequently Asked Questions
How does the brain protect itself during low oxygen?
Brain cells detect low oxygen and increase production of adrenomedullin, a vasodilator. This relaxes brain blood vessels to restore blood flow. The cells also increase the receptor for this peptide, ensuring the signal is received.
Could this help stroke patients?
If we can enhance this natural protective response — either by administering adrenomedullin or by boosting its production — it might protect brain tissue during stroke and reduce brain damage.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00600APA
Ladoux, A; Frelin, C. (2000). Coordinated Up-regulation by hypoxia of adrenomedullin and one of its putative receptors (RDC-1) in cells of the rat blood-brain barrier.. The Journal of biological chemistry, 275(51), 39914-9.
MLA
Ladoux, A, et al. "Coordinated Up-regulation by hypoxia of adrenomedullin and one of its putative receptors (RDC-1) in cells of the rat blood-brain barrier.." The Journal of biological chemistry, 2000.
RethinkPeptides
RethinkPeptides Research Database. "Coordinated Up-regulation by hypoxia of adrenomedullin and o..." RPEP-00600. Retrieved from https://rethinkpeptides.com/research/ladoux-2000-coordinated-upregulation-by-hypoxia
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.